Stock Earnings

Question 1

What are Eli Lilly and Co's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Eli Lilly and Co has a total asset of $112,476, Net profit of $20,640

Question 2

What are the key financial ratios for LLY?

Accepted Answer

Eli Lilly and Co's Current ratio is 1.3, has a Net margin is 31.66, sales per share of $72.47.

Question 3

How is Eli Lilly and Co's revenue broken down by segment or geography?

Accepted Answer

Eli Lilly and Co largest revenue segment is Glucagon, at a revenue of 32,500,000 in the most earnings release.For geography, US Revenue is the primary market for Eli Lilly and Co, at a revenue of 43,481,000,000.

Question 4

Is Eli Lilly and Co profitable?

Accepted Answer

yes, according to the latest financial statements, Eli Lilly and Co has a net profit of $20,640

Question 5

Does Eli Lilly and Co have any liabilities?

Accepted Answer

yes, Eli Lilly and Co has liability of 85,941

Question 6

How many outstanding shares for Eli Lilly and Co?

Accepted Answer

Eli Lilly and Co has a total outstanding shares of 944.8

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	79,665	65,179	45,042	34,124	28,541	28,318
Revenue Growth (YoY)	50%	45%	32%	20%	1%	15%
Cost of Revenue	13,225	11,052	8,418	7,082	6,629	7,312
Gross Profit	66,440	54,127	36,624	27,041	21,911	21,005
Selling, General & Admin	12,236	11,094	8,593	7,403	6,440	6,431
Research & Development	14,596	13,337	10,990	9,313	7,190	7,025
Operating Expenses	26,832	24,431	19,584	16,716	13,631	13,457
Other Non Operating Income (Expenses)	929	324	436	429	358	341
Pretax Income	33,595	25,731	12,680	6,554	6,806	6,155
Income Tax Expense	6,884	5,091	2,090	1,314	561	573
Net Income	26,711	20,640	10,590	5,240	6,244	5,581
Net Income Growth	94%	95%	102%	-16%	12%	-10%
Shares Outstanding (Diluted)	893.7	899.3	904.05	903.28	904.61	911.68
Shares Change (YoY)	-1%	-1%	0%	0%	-1%	0%
EPS (Diluted)	29.88	22.95	11.71	5.8	6.9	6.12
EPS Growth	95%	96%	102%	-16%	13%	-10%
Free Cash Flow	13,559	5,964	414	-3,152	4,600	5,387
Free Cash Flow Per Share	15.17	6.63	0.45	-3.48	5.08	5.9
Gross Margin	83.39%	83.04%	81.31%	79.24%	76.77%	74.17%
Operating Margin	49.71%	45.56%	37.83%	30.25%	29.01%	26.65%
Profit Margin	33.52%	31.66%	23.51%	15.35%	21.87%	19.7%
Free Cash Flow Margin	17.02%	9.15%	0.91%	-9.23%	16.11%	19.02%
EBITDA	41,706	31,693	18,806	11,852	9,802	9,095
EBITDA Margin	52.35%	48.62%	41.75%	34.73%	34.34%	32.11%
D&A For EBITDA	2,098	1,997	1,766	1,527	1,522	1,547
EBIT	39,608	29,696	17,040	10,325	8,280	7,548
EBIT Margin	49.71%	45.56%	37.83%	30.25%	29.01%	26.65%
Effective Tax Rate	20.49%	19.78%	16.48%	20.04%	8.24%	9.3%

Eli Lilly and Co (LLY) Price

LLY Stock Price Chart

LLY Income

Follow-Up Questions